Dealing with Menopausal Sleep Disturbances

Sleep Medicine Clinics

Volumn 3, Issue 1, 2008, Pages 121-131

  Polo Kantola, Päivi ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CLONIDINE; CYCLIC AMP; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GABAPENTIN; GESTAGEN; GLUTAMIC ACID; GROWTH HORMONE; HYDROCORTISONE; MEDROXYPROGESTERONE ACETATE; MELATONIN; MIRTAZAPINE; PLACEBO; PROGESTERONE; PROLACTIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; VASOPRESSIN;

AGING; CLIMACTERIUM; CLINICAL TRIAL; COGNITIVE THERAPY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERSOMNIA; MENOPAUSAL SYNDROME; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAXATION TRAINING; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SWEATING; VASOMOTOR DISORDER; WEIGHT GAIN;

EID: 64749087721     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2007.10.006     Document Type: Review

References (116)

1. American Sleep Disorders Association: Diagnostic Classification Steering Committee. International classification of sleep disorders. Diagnostic and coding manual. Rochester (MN); 1990.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1993), APA, Washington, DC, USA
3. Moul D.E., Nofzinger E.A., Pilkonis P.A., et al. Symptom reports in severe chronic insomnia. Sleep 25 (2002) 553-563
4. Speroff L. The menopause. A signal for the future. In: Lobo R.A. (Ed). Treatment of the postmenopausal woman: basic and clinical aspects (1994), Raven Press Ltd, New York 1-8
5. Wise P.M., Krajnak K.M., and Kashon M.L. Menopause: the aging of multiple pacemakers. Science 273 (1996) 67-70
6. McKinlay S.M., Brambilla B.J., and Posner J.G. The normal menopausal transition. Maturitas 14 (1992) 103-115
7. World Health Organization (WHO) Scientific Group. In: Research on the menopause in the 1990s. Geneva; 1996. p. 12-21.
8. International Menopause Society. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10 (2007) 181-194
9. Sturdee D.W., and Reece B.L. Thermography of menopausal hot flushes. Maturitas 1 (1979) 201-205
10. Freedman R.R. Physiology of hot flashes. Am J Hum Biol 13 (2001) 453-464
11. Freedman R.R. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 23 2 (2005) 117-125
12. Collins A., and Landgren B.M. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population based study. Maturitas 20 (1994) 101-111
13. Oldenhave A., Jaszmann L.J., Haspels A.A., et al. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 168 (1993) 772-780
14. Moe K.E. Hot flashes and sleep in women. Sleep Med Rev 8 (2004) 487-497
15. Guttuso T., Kurlan R., McDermott M., et al. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Am J Obstet Gynecol 101 2 (2003) 337-345
16. Belchetz P.E. Drug therapy: hormonal treatment of postmenopausal women. N Engl J Med 330 (1994) 1062-1071
17. Rodstrom K., Bengtsson C., Lissner L., et al. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of the century. Menopause 9 (2002) 156-161
18. Milsom I. Menopause-related symptoms and their treatment. In: Erkkola R. (Ed). The menopause (2006), Elsevier 9-16
19. Erkkola R., Holma P., Järvi T., et al. Transdermal oestrogen replacement therapy in a Finnish population. Maturitas 13 (1991) 275-281
20. Toran-Allerand C.D. Novel sites and mechanisms of oestrogen action in the brain. Novartis Found Symp 230 (2000) 56-69
21. Sherwin B.B. Hormones, mood and cognitive functioning in postmenopausal women. Obstet Gynecol 87 Suppl (1996) 20-26
22. Natale V., Albertazzi P., Zini M., et al. Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations. Int J Obstet Gynecol 108 (2001) 286-290
23. Moss R.L., Gu Q., and Wong M. Estrogen: nontranscriptional signalling pathway. Recent Prog Horm Res 52 (1997) 33-68
24. Koehler K.F., Helguero L.A., Haldosen L.-A., et al. Reflections on the discovery and significance of estrogen receptor β. Endocr Rev 26 3 (2005) 465-478
25. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr Rev 20 (1999) 279-307
26. In: Shneerson J.M. (Ed). Handbook of sleep medicine. 1st edition (2000), Blackwell Science Ltd, Oxford (UK) 237
27. Barrett-Connor E. Rethinking estrogen and the brain. J Am Geriatr Soc 46 (1998) 90-92
28. Rapkin A.J. Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol 196 (2007) 97-106
29. Dzaja A., Arber S., Hislop J., et al. Women's sleep in health and disease. J Psychiatr Res 39 (2005) 55-76
30. Fonseca E., Ochoa R., Galván R., et al. Increased serum levels of growth hormone and insulin-like growth factor-I associated with simultaneous decrease of circulating insulin in postmenopausal women receiving hormone replacement therapy. Menopause 6 (1999) 56-60
31. Fernandez B., Malde J.L., Montero A., et al. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J Steroid Biochem 35 (1990) 257-262
32. Woods N.F., Carr M.C., Tao E.Y., et al. Increased urinary cortisol levels during the menopausal transition. Menopause 13 (2006) 212-221
33. Moe K.E., Prinz P.N., Larsen L.H., et al. Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy. J Gerontol A Biol Sci Med Sci 53A (1998) B117-B124
34. Bellantoni M.F., Vittone J., Campfield A.T., et al. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81 (1996) 2848-2853
35. Weissberger A.J., Ho K.K.Y., and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72 (1991) 374-381
36. Cano A., Castelo-Branco C., and Tarin J.J. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil Steril 71 (1999) 261-267
37. Katznelson L., Riskind P.N., Saxe V.C., et al. Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab 83 (1998) 761-764
38. Chang R.J., Davidson B.J., Carlson H.E., et al. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin. Am J Obstet Gynecol 144 (1982) 402-407
39. Bernardi F., Pieri M., Stomati M., et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 17 (2003) 65-77
40. Pluchino N., Genazzani A.D., Bernardi F., et al. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol 20 (2005) 144-149
41. Gudmundsson A., Goodman B., Lent S., et al. Effects of estrogen replacement therapy on the circadian rhythms of serum cortisol and body temperature in postmenopausal women. Exp Gerontol 34 (1999) 809-818
42. Fonseca E., Basurto L., Veláquez S., et al. Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause. Maturitas 39 (2001) 57-62
43. Ohayon M. Epidemiological study on insomnia in the general population. Sleep 19 (1996) 7-15
44. Leger D., Guilleminault C., Dreyfus J.P., et al. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res 9 (2000) 35-42
45. Zhang B., and Wing Y.K. Sex differences in insomnia: a meta-analysis. Sleep 29 1 (2006) 85-93
46. Ledesert B., Ringa V., and Breart G. Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 20 (1994) 113-120
47. Kuh D.L., Wadsworth M., and Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 104 (1997) 923-933
48. Kravitz H.M., Ganz P.A., Bromberger J., et al. Sleep difficulty in women at midlife. Menopause 10 (2003) 19-28
49. Anderson E., Hamburger S., Liu J.H., et al. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 156 (1987) 428-433
50. Shaver J., Giblin E., Lentz M., et al. Sleep patterns and stability in perimenopausal woman. Sleep 11 (1988) 556-561
51. Baker A., Simpson S., and Dawson D. Sleep disruption and mood changes associated with menopause. J Psychosom Res 43 (1997) 359-369
52. Polo-Kantola P., Erkkola R., Irjala K., et al. Climacteric symptoms and sleep quality. Obstet Gynecol 94 (1999) 219-224
53. Thurston R.C., Blumenthal J.A., Babyak M.A., et al. Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 13 2 (2006) 163-172
54. Erlik Y., Tataryn I.V., Meldrum D.R., et al. Association of waking episodes with menopausal hot flushes. JAMA 245 (1981) 1741-1744
55. Young T., Rabago D., Zgierska A., et al. Objective and subjective sleep quality in pre-, peri- and postmenopausal women in the Wisconsin sleep cohort study. Sleep 26 (2003) 667-672
56. Sharkey K.M., Bearpark H.M., Acebo C., et al. Effects of menopausal status on sleep in midlife women. Behav Sleep Med 1 (2003) 69-80
57. Woodward S., and Freedman R.R. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 17 6 (1994) 497-501
58. Freedman R.R., and Roehrs T.A. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 82 (2004) 138-144
59. Freedman R.R., and Roehrs T.A. Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause 13 4 (2006) 576-583
60. Freedman R.R., and Roehrs T.A. Sleep disturbance in menopause. Menopause 14 5 (2007) 826-829
61. Rees M. The use of hormone replacement therapy in Europe and around the world. In: Erkkola R. (Ed). The menopause (2006), Elsevier 255-259
62. Wiklund I., Berg G., Hammar M., et al. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 14 (1992) 225-236
63. Rosen C.J. Postmenopausal osteoporosis. N Engl J Med 353 (2005) 595-603
64. Samsioe G. Current views on hormone replacement therapy and cardiovascular disease. In: Erkkola R. (Ed). The menopause (2006), Elsevier 63-80
65. Hays J., Ockene J.K., Brunner R.L., et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348 (2003) 1839-1854
66. Wiklund I., Karlberg J., and Mattsson L.-A. Quality of life of menopausal women on a regimen of transdermal estradiol therapy: a double blind place-controlled study. Am J Obstet Gynecol 168 (1993) 824-830
67. Polo-Kantola P., Erkkola R., Helenius H., et al. When does estrogen replacement therapy improve sleep quality?. Am J Obstet Gynecol 178 (1998) 1002-1009
68. Gambacciani M., Ciaponi M., Cappagli B., et al. Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 44 (2003) 157-163
69. Thomson J., and Oswald I. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. BMJ 2 (1977) 1317-1319
70. Schiff I., Regestein Q., Tulchinsky D., et al. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 242 (1979) 2405-2407
71. Antonijevic I.A., and Stalla G.K. Steiger A Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 182 (2000) 277-282
72. Scharf M.B., McDannold M.D., Stover R., et al. Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot study. Clin Ther 19 (1997) 304-311
73. Polo-Kantola P., Erkkola R., Irjala K., et al. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 71 (1999) 873-880
74. Montplaisir J., Lorrain J., Denesle R., et al. Sleep in menopause: differential effects of two forms of hormone replacement therspy. Menopause 8 (2001) 10-16
75. Moe K.E., Larsen L.H., Vitiello M.V., et al. Estrogen replacement therapy modulates the sleep disruption associated with nocturnal blood sampling. Sleep 24 (2001) 886-894
76. Pickett C.K., Regensteiner J.G., Woodard W.D., et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 66 (1989) 1656-1661
77. Purdie D.W., Empson J.A.C., Crichton C., et al. Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol 102 (1995) 735-739
78. Saletu-Zyhlarz G., Anderer P., Gruber G., et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination versus estrogen alone. J Sleep Res 12 (2003) 239-254
79. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592 (1990) 52-86
80. Miller R.G., and Ashar B.H. Managing menopause: current therapeutic options for vasomotor symptoms. Adv Stud Med 4 (2004) 484-492
81. Mazur W., and Adlercreutz H. Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 16 (2000) 654-658
82. Speroff L. Alternative therapies for postmenopausal women. Int J Fertil Womens Med 50 3 (2005) 101-114
83. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 23 Suppl 1 (2000) S23-S30
84. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
85. Manber R., and Armitage R. Sex, steroids, and sleep: a review. Sleep 22 (1999) 540-555
86. Skatrud J.B., Dempsey J.A., and Kaiser D.G. Ventilatory responses to medroxyprogesterone acetate in normal subjects: time course and mechanism. J Appl Physiol 44 (1978) 939-944
87. Regensteiner J.G., Woodard W.D., Hagerman D.D., et al. Combined effects of female hormones and metabolic rate on ventilatory drives in women. J Appl Physiol 66 (1989) 808-813
88. Popovic R.M., and White D.P. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 84 (1998) 1055-1062
89. Villaneuva A.T., Buchanan P.R., Yee B.J., et al. Ethnicity and obstructive sleep apnoea. Sleep Med Rev 9 6 (2005) 419-436
90. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
91. Gislason T., Benediktsdottir B., Bjornsson J.K., et al. Snoring, hypertension, and the sleep apnea syndrome. An epidemiologic survey of middle-aged women. Chest 103 (1993) 1147-1151
92. Bixler E.O., Vgontzas A.N., Lin H.-M., et al. Prevalence of sleep-disordered breathing in women. Effect of gender. Am J Respir Crit Care Med 163 (2001) 608-613
93. Anttalainen U., Saaresranta T., Kalleinen N., et al. Gender differences in age and BMI distributions in partial upper airway obstruction during sleep. Respir Physiol Neurobiol 159 2 (2007) 219-226
94. Polo-Kantola P., Rauhala E., Helenius H., et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 102 (2003) 68-75
95. Anttalainen U., Saaresranta T., Kalleinen N., et al. CPAP adherence and partial upper airways obstruction during sleep. Sleep Breath 11 (2007) 171-176
96. Grunstein R.R. Continuous positive airway pressure treatment for obstructive sleep apnea-hypopnea syndrome. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine (2005), Elsevier Saunders, Philadelphia 1066-1080 Chapter 89
97. Buchanan P.R., and Grunstein R.R. Neuropharmagology of obstructive sleep apnea and central apnea. In: Pandi-Perumal S.R., and Monti J.M. (Eds). Clinical pharmacology of sleep (2006), Birkhäuser Verlag, Switzerland 21-41
98. Carley D.W., Olopade C., Seink S., et al. Serotonin antagonist improves obstructive sleep apnea. Sleep Med 4 Suppl 1 (2003) S1-S56
99. Shahar E., Redline S., Young T., et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167 (2003) 1186-1192
100. Cistulli P.A., Barnes D.J., Grunstein R.R., et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 49 (1994) 699-702
101. Keefe D.L., Watson R., and Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 6 (1999) 196-200
102. Block A.J., Wynne J.W., Boysen P.G., et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 70 (1981) 506-510
103. Saaresranta T., Polo-Kantola P., Irjala K., et al. Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Chest 115 (1999) 1581-1587
104. Ford D.E., and Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. JAMA 262 (1989) 1479-1484
105. Johnson E.O., Roth T., and Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 40 8 (2006) 700-708
106. Kornstein S.G. Gender differences in depression: implications for treatment. J Clin Psychiatry 58 (1997) 12-18
107. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60 (1999) 4-15
108. Avis N.E., Stellato R., Crawford S., et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52 (2001) 345-356
109. Sakkas P., and Soldatos C.R. Primary insomnia: diagnosis and treatment. In: Pandi-Perumal S.R., and Monti J.M. (Eds). Clinical pharmacology of sleep (2006), Birkhäuser Verlag, Switzerland 11-19
110. Lichstein K.L., Gellis L.A., Stone K.C., et al. Primary and secondary insomnia. In: Pandi-Perumal S.R., and Monti J.M. (Eds). Clinical pharmacology of sleep (2006), Birkhäuser Verlag, Switzerland 1-9
111. Genazzani A.R., Cambacciani M., Cappagli B., et al. Endocrinology of the menopause. In: Erkkola R. (Ed). The menopause (2006), Elsevier 1-8
112. Rothdach A.J., Trenkwalder C., Haberstock J., et al. Prevalence and risk factors of RLS in elderly population. The MEMO study. Neurology 54 (2000) 1064-1068
113. Zucconi M., and Ferini-Strambi L. Epidemiologic and clinical findings of restless legs syndrome. Sleep Med 5 (2004) 293-299
114. Manconi M., Covoni V., De Vito A., et al. Restless legs syndrome and pregnancy. Neurology 63 (2004) 1065-1069
115. Nikkola E., Ekblad U., Ekholm E., et al. Sleep in multiple pregnancy: breathing patterns, oxygenation, and periodic leg movements. Am J Obstet Gynecol 174 5 (1996) 1622-1625
116. Polo-Kantola P., Rauhala E., Erkkola R., et al. Estrogen replacement therapy and nocturnal periodic limb movements: a randomized trial. Obstet Gynecol 97 (2001) 548-554